Skip to content
★ Sign in to follow
SP

Sanjeev Pandya

Board Director
ImmuPharma PLC
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€12k
▼ Sales (0 ops.)
—

Latest filing published 24 Aug 2021 for ImmuPharma PLC, €12k.

Filing timeline

BuySale
Sanjeev Pandya

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 24 Aug 2021 · 1902 days ago · €12k
    -20.5%
    Entry 8.05 · Close at T+365 6.40

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Sanjeev Pandya: trading record in brief

Our data holds just one disclosure by Sanjeev Pandya, dated 24 August 2021, reporting an open-market purchase worth €12k in ImmuPharma PLC. Further filings will be added here. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.

Companies and markets linked to Sanjeev Pandya

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Senior Non-Executive DirectorExecutivesImmuPharma PLC
    10,000 GBP33FCA-NSM
    125,000 shares@ £0.08100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB0033711010FCA-NSM:4088513-2
    Canonical exit: 21 Nov 2021 (T+90)

1 of 1 declaration